THCH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. THCH is in a clear bearish trend (bearish MA stack and weakening MACD), is trading below the first support (2.036) in the post-market (1.99), and there are no near-term news catalysts or supportive analyst upgrades to justify stepping in immediately. Any bounce setup is not confirmed and proprietary signals are absent, so the risk/reward favors avoiding or exiting rather than buying today.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum is deteriorating: MACD histogram is negative (-0.0268) and expanding lower, which typically signals selling pressure is increasing. RSI_6 ~32 is near oversold but still not showing a confirmed reversal—this can stay depressed in downtrends. Key levels: Pivot 2.247; resistance 2.457/2.586; support 2.036 then 1.907. With post-market near 1.99, price is below S1 (2.036) and drifting toward S2 (1.907), so technicals do not support an immediate buy for someone unwilling to wait for confirmation.
can enable a short-term technical bounce if buyers reclaim S1 (~2.
quickly. Open-interest skew is call-heavy (low put/call OI ratio), which is mildly supportive if a catalyst appears. Pattern-based projection in the dataset suggests modest upside probabilities over 1W/1M, but the edge is small.
No news in the recent week—no obvious event-driven catalyst to reverse the downtrend. Bearish moving averages and a negatively expanding MACD indicate trend and momentum are still worsening. Price is trading below first support (S1), increasing odds of a move toward S2 (~1.907). Options market is effectively illiquid (zero volume), reducing the usefulness of options sentiment and making positioning/hedging difficult.
Latest quarter: 2025/Q3. Revenue fell to 358,018,000 (-0.43% YoY), while Net Income was a deeper loss at -72,894,000 (down -17.96% YoY). This points to stagnating top-line with worsening profitability, which is not supportive of a near-term bullish entry without a clear turnaround catalyst.
No analyst rating/price target change data was provided, so there is no evidence of recent Wall Street upgrades or raised targets to support buying. With the available information, the 'pros' case is limited to a potential oversold bounce; the 'cons' case is dominant (downtrend + weakening momentum + deteriorating profitability + no catalysts).
